Journals / Gaziantep Medical Journal / 2015 / Cilt: 21 - Sayı: 2

Baş dönmesi, halsizlik ve nöropsikiyatrik semptomlar ile prezente olan Creutzfeldt-Jakob hastalığı: 2 olgu sunumu

Creutzfeldt-Jakob disease presented with dizziness, weakness and neuropsychiatric symptoms: 2 Case Reports

Pages
142–146
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

CJD, which is a very rare disease in patients presenting with progressive neuropsychiatric symptoms and seizure, is one of the diagnosis to be considered and we wanted to emphasize that there is no treatment for it and preventive measures should be taken.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Creutzfeldt-Jakob disease (CJD) is among very rare, progressive, untreatable, neurodegenerative prion diseases.
📊
Key Findings & Data:While the incidence is reported as 1/1000000 years in European countries, sporadic cases are rarely presented in Turkey.
💡
Conclusion & Impact:CJD, which is a very rare disease in patients presenting with progressive neuropsychiatric symptoms and seizure, is one of the diagnosis to be considered and we wanted to emphasize that there is no treatment for it and preventive measures should be taken.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Creutzfeldt-Jakob disease (CJD) is among very rare, progressive, untreatable, neurodegenerative prion diseases. While the incidence is reported as 1/1000000 years in European countries, sporadic cases are rarely presented in Turkey. Clinical findings are in the form of rapid progressive dementia, myoclonus, cerebellar, pyramidal and extra pyramidal symptoms. Definitive diagnosis is established by histopathological examination. Our case is a 64-year-old male and 70-year-old female patients admitted with dizziness emerged as sub-acute weakness, nausea, vomiting, insomnia, imbalance and additional neuropsychiatric complaints. Focal activity slowness and common periodic sharp wave activities were observed in EEG. CJD was considered because bilateral symmetrical diffusion limitation was observed at both sides in the basal ganglia level in cranial diffusion MRI s and 14-3-3 protein was resulted as positive in CSF examinations. CJD, which is a very rare disease in patients presenting with progressive neuropsychiatric symptoms and seizure, is one of the diagnosis to be considered and we wanted to emphasize that there is no treatment for it and preventive measures should be taken.

Özet

Creutzfeldt-Jakob Hastalığı (CJH) çok nadir görülen, ilerleyici, tedavisi mümkün olmayan nörodejeneratif prion hastalıkları arasındadır. Avrupa ülkelerinde insidansı yılda 1/1000000 olarak bildirilmekte iken, Türkiyede nadiren sporadik vakalar sunulmaktadır. Klinik bulgular hızlı ilerleyen progresif demans, myoklonus, serebellar, piramidal ve extra pramidal semptomlar şeklindedir. Kesin tanı histopatolojik inceleme ile konulmaktadır. Bizim olgumuz 64 yaşında erkek ve 70 yaşında bayan hastalar subakut olarak ortaya çıkan baş dönmesi, halsizlik, bulantı kusma, uykusuzluk, dengesini sağlayamama ve eklenen nöropsikiyatrik şikayetler ile başvurdular. EEG lerinde zemin aktivite yavaşlığı ve yaygın periyodik keskin dalga aktivitesi izlendi. Kranial difüzyon MRG' larda her iki tarafta bazal ganglionlar düzeyinde bilateral simetrik diffüzyon kısıtlaması izlenmesi ve BOS incelemesinde 14-3-3 proteinin pozitif olarak sonuçlanması nedeniyle CJH düşünüldü. İlerleyici nöropsikiyatrik bulgular ve nöbetle başvuran hastalarda çok nadir görülen bir hastalık olan CJH akla gelmesi gereken tanılardan bir tanesi olup, tedavisi olmamakla beraber koruyucu önlemlerin alınması gerektiğini vurgulamak istedik.

🔖

Cite This Article

İNANÇ, Y., GİRAY, S., GEYİK, S., İNANÇ, Y., ARLIER, Z., KOCATÜRK, Ö. (2022). Baş dönmesi, halsizlik ve nöropsikiyatrik semptomlar ile prezente olan Creutzfeldt-Jakob hastalığı: 2 olgu sunumu. Gaziantep Medical Journal, Cilt: 21 - Sayı: 2, 142–146. https://ajindex.com/articles/518293

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Glatzel M, Stoeck K, Seeger H, Lührs T, Aguzzi A. Human prion diseases molecular and clinical aspects. Arch Neurol. 2005;62(4):545-52
  2. MT, Will RG, Manson JC. Defining sporadic CreutzfeldtJakob disease strains and their transmission properties. Proc Natl Acad Sci U S A. 2010; 107(26): 12005–10
  3. Fujita K, Harada M, Sasaki M, Yuasa T, Sakai K, Hamaguchi T et al. Multicentre multiobserver study of diffusionweighted and fluid-attenuated inversion recovery MRI for the diagnosis of sporadic Creutzfeldt–Jakob disease: a reliability and agreement study. BMJ Open. 2012; 2(1): e000649
  4. Thompson A, MacKay A, Rudge P, Lukic A, Porter MC, Lowe J et al. Behavioral and psychiatric symptoms in prion disease. Am J Psychiatry. 2014 Mar;171(3):265-74
  5. Jubelt B, Miller JR. Viral infections. In: Rowland LP,ed. Merrit's Textbook of Neurology. 9th Ed. Philadelphia Williams and Wilkins 1995; 142-179
  6. Jonathan D. F. Wadsworth, John Collinge. Molecular pathology of human prion disease. Acta Neuropathol. 2011; 121(1): 69–77
  7. Maltete D, Guyant Marechal L, Mihout B. Movement disorders and Creutzfeldt-Jakob disease: A review. Parkinsonism and Related Disorders 2006; 12(2): 65-71
  8. Wieser HG, Schindler K, Zumsteg D. EEG in Creutzfeldt-Jakob disease. Clin. Neurophysiol. 2006;117(5):935-51
  9. Cambier DM, Kantarci K, Worrell GA et all. Lateralized and focal clinical, EEG, and FLAIR MRI abnormalities in Creutzfeldt-Jakob disease. Clin Neurophysiol. 2003;114(9):1724-28
  10. Green AJ, Thompson EJ, Stewart GE, Zeidler M, McKenzie JM, MacLeod MA et al. Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant CreutzfeldtJakob disease. J Neurol Neurosurg Psychiatry. 2001 Jun;70(6):744-8
  11. Van Everbroeck B, Boons J, Cras P. Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease. Clin Neurol Neurosurg 2005; 107(5):355-60
  12. Caobelli F, Cobelli M, Pizzocaro C, Pavia M, Magnaldi S, Guerra UP. The Role of Neuroimaging in Evaluating Patients Affected by Creutzfeldt-Jakob Disease: A Systematic Review of the Literature. J Neuroimaging. 2014; 5. doi: 10.1111
  13. Bergui M, Bradac GB, Rossi G, Orsi L. Extensive cortical damage in a case of Creutzfeldt-Jakob disease: Clinicoradiological correlations. Neuroradiology. 2003;45(5):304-7.